MedTrace Logo

Chemotherapy-related Cognitive Impairment and Acute Leukemia

NCT04644419 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2023-05-06

No results posted yet for this study

Summary

This is an ancillary study of an intervention study (NCT04570709). The parent study is a single institution, feasibility trial of 20 (10 control and 10 intervention) patients with the primary objective of assessing feasibility, acceptability, and change in pre and post measures of symptoms, function, and quality of life by administering the Palliative and Collaborative Care InTervention (PACT). We will further assess cognitive function in the patients who participate in the control of the parent study.

Conditions

Interventions

OTHER

none (observational study)

This is an observational study and does not include intervention delivery.

Sponsors & Collaborators

  • American Cancer Society, Inc.

    collaborator OTHER

  • UNC Lineberger Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Ya-Ning Chan, MSN, RN · University of North Carolina, Chapel Hill

  • Ashley L Bryant, PhD, RN · University of North Carolina, Chapel Hill

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-03
Primary Completion
2022-10-15
Completion
2023-05-03

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04644419 on ClinicalTrials.gov